Respiratory Infections News

Respiratory syncytial virus vaccines proved highly effective at preventing hospitalization and ED visits in older adults, even in those with immunocompromising conditions, results from an observational analysis showed.

More than half of children with acute otitis media and 32% of children with upper respiratory infections tested positive for multiple pathogens in their nasal passages, according to a study presented at IDWeek.

The United States Department of Agriculture this week confirmed the first case of highly pathogenic H5N1 avian influenza in a U.S. pig, raising concerns about the potential health risk to humans.

There was a “marked decrease” in COVID-19 vaccine uptake among nursing home personnel last season, according to researchers, who attributed the decline to cost and the end of the CMS’s COVID-19 vaccine requirement in mid-2023.

Data from a phase 3 trial designed to compare pralsetinib with standard therapy for certain patients with advanced lung cancer revealed a risk for severe — and potentially fatal — infections with the drug, according to its manufacturer.

The simultaneous administration of adjuvant zoster and influenza vaccines posed no additional safety risks in older adults, results from a randomized study showed.

New diagnoses of autoimmune diseases were not overall more likely among vaccinated patients infected with omicron or delta variants of COVID-19, compared with those not infected, according to data published in JAMA Network Open.

A CDC advisory committee on Wednesday recommended that adults aged 65 years or older and anyone who is at least moderately immunocompromised receive a second dose of COVID-19 vaccine this season.

Another monoclonal antibody for preventing respiratory syncytial virus disease in infants could enter the market as early as next year, based on the results of two studies presented at IDWeek, Merck said.

LOS ANGELES — Paxlovid reduced the risk for severe COVID-19 hospitalization or death among people with existing immunity from a previous infection or vaccination, according to pooled trial data presented at IDWeek.